The lower fee comes as big device makers lobbied hard against the proposed $40 million fee, enlisting senators in their home states of Minnesota, California, Massachusetts and elsewhere.
The original reform bills in the U.S. House did not have a device fee, but House Democrats are now devising an excise tax on medical devices, to be paid at the point of sale, that would yield a total of $20 billion between 2013 and 2019.
Read the Wall Street Journal’s report on the proposed medical device fee.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
